Targeting Autophagy in ALK-Associated Cancers.

Area of Science:

• Cellular Biology
• Molecular Oncology
• Cancer Therapeutics

Background:

• Autophagy is a conserved catabolic process crucial for cytoplasmic quality control.
• It acts as a cell survival mechanism under stress but can also induce cell death.
• This duality is significant in cancer development and therapy.

Purpose of the Study:

• To review the dual role of autophagy in cancer, specifically its impact on cell survival and death.
• To focus on the current understanding of autophagy in Anaplastic Lymphoma Kinase (ALK)-associated cancers.
• To discuss the therapeutic modulation of autophagy in cancer treatment.

Main Methods:

• Literature review of autophagy's role in cancer.
• Focus on studies involving ALK-associated malignancies.
• Analysis of autophagy's impact on cell fate and therapeutic outcomes.

Main Results:

• Autophagy's role in cancer is context-dependent, influencing both tumor progression and treatment response.
• Autophagy has been observed in various ALK-associated cancers, including ALK-positive anaplastic large cell lymphoma (ALCL), non-small cell lung carcinoma (NSCLC), neuroblastoma (NB), and rhabdomyosarcoma (RMS).

Conclusions:

• Autophagy's complex role in cancer necessitates careful consideration for therapeutic strategies.
• Targeting autophagy in ALK-associated cancers presents a promising avenue for improving patient outcomes.
• Further research is needed to fully elucidate and exploit autophagy's therapeutic potential in these cancers.